Advances in our understanding of the molecular defects underlying this
leukemia have led to novel therapeutic approaches that have not only
altered the natural history of the disease but also apparently effecte
d cures in some patients. The next step may be to offer the possibilit
y of a cure to all patients. Allogeneic bone marrow and T cell transpl
antation shows promise in this regard.